Delivery optimization of erlotinib according to toxicity: May clinical practice go beyond research?

Antonio Passaro, Morena Fasano, Emilio Bria, Floriana Morgillo, Flavia Cantile, Daniele Alesini, Arianna Pellegrino, Enrico Cortesi, Fortunato Ciardiello

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)352-353
Number of pages2
JournalLung Cancer
Volume80
Issue number3
DOIs
Publication statusPublished - Jun 2013

Keywords

  • EGFR TKI
  • Erlotinib
  • NSCLC
  • Second-line

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this